JP2005508910A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005508910A5 JP2005508910A5 JP2003530275A JP2003530275A JP2005508910A5 JP 2005508910 A5 JP2005508910 A5 JP 2005508910A5 JP 2003530275 A JP2003530275 A JP 2003530275A JP 2003530275 A JP2003530275 A JP 2003530275A JP 2005508910 A5 JP2005508910 A5 JP 2005508910A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- group
- halo
- alkoxy
- optionally substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 *C(*)(*)CC(*)(*)*=*CNC(*)=N Chemical compound *C(*)(*)CC(*)(*)*=*CNC(*)=N 0.000 description 5
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/961,521 US20030119826A1 (en) | 2001-09-24 | 2001-09-24 | Neuroprotective treatment methods using selective iNOS inhibitors |
| PCT/US2002/030214 WO2003026638A1 (en) | 2001-09-24 | 2002-09-24 | Neuroprotective treatment methods using selective inos inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005508910A JP2005508910A (ja) | 2005-04-07 |
| JP2005508910A5 true JP2005508910A5 (enExample) | 2006-01-05 |
Family
ID=25504581
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003530275A Pending JP2005508910A (ja) | 2001-09-24 | 2002-09-24 | 選択的ｉＮＯＳ阻害剤を用いる神経保護的な治療方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20030119826A1 (enExample) |
| EP (1) | EP1429752A1 (enExample) |
| JP (1) | JP2005508910A (enExample) |
| KR (1) | KR20040039394A (enExample) |
| CN (1) | CN1556698A (enExample) |
| AU (1) | AU2002327042A2 (enExample) |
| BR (1) | BR0212989A (enExample) |
| CA (1) | CA2455989A1 (enExample) |
| IL (1) | IL161005A0 (enExample) |
| MX (1) | MXPA04002710A (enExample) |
| PL (1) | PL371774A1 (enExample) |
| WO (1) | WO2003026638A1 (enExample) |
| ZA (1) | ZA200402288B (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8314124B2 (en) * | 2004-02-06 | 2012-11-20 | Active Biotech Ab | Crystalline salts of quinoline compounds and methods for preparing them |
| SG10201508623RA (en) * | 2005-10-19 | 2015-11-27 | Teva Pharma | Crystals of laquinimod sodium, and process for the manufacture thereof |
| KR20150065951A (ko) * | 2006-06-12 | 2015-06-15 | 테바 파마슈티컬 인더스트리즈 리미티드 | 안정한 라퀴니모드 제제 |
| WO2009082471A1 (en) | 2007-12-20 | 2009-07-02 | Teva Pharmaceutical Industries, Ltd. | Stable laquinimod preparations |
| MX2011002033A (es) * | 2008-09-03 | 2011-05-02 | Teva Pharma | 2-oxo-1,2-dihidro-quinolinas moduladoras de la funcion inmune. |
| ES2564931T3 (es) * | 2009-07-30 | 2016-03-30 | Teva Pharmaceutical Industries Ltd. | Tratamiento de enfermedad de Crohn con laquinimod |
| CA2771203C (en) * | 2009-08-10 | 2019-04-09 | Teva Pharmaceutical Industries Ltd. | Treatment of bdnf-related disorders using laquinimod |
| EP2766020A4 (en) | 2011-10-12 | 2015-04-01 | Teva Pharma | TREATMENT OF MULTIPLE SCLEROSIS BY COMBINING LAQUINIMOD AND FINGOLIMOD |
| AR089862A1 (es) | 2012-02-03 | 2014-09-24 | Teva Pharma | USO DE LAQUINIMOD PARA EL TRATAMIENTO DE PACIENTES CON ENFERMEDAD DE CROHN EN QUIENES FRACASO UNA TERAPIA ANTI-FACTOR DE NECROSIS TUMORAL a (ANTI-TNFa) DE PRIMERA LINEA |
| TW201400117A (zh) | 2012-06-05 | 2014-01-01 | Teva Pharma | 使用拉喹莫德治療眼發炎疾病 |
| MX2015005632A (es) | 2012-11-07 | 2016-02-05 | Teva Pharma | Sales de amina de laquinimod. |
| EP2970129A2 (en) | 2013-03-14 | 2016-01-20 | Teva Pharmaceutical Industries Ltd. | Crystals of laquinimod sodium and improved process for the manufacture thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE295832T1 (de) * | 2000-03-24 | 2005-06-15 | Pharmacia Corp | Amidino-verbindung sowie salze davon verwendbar als hemmstoffe der stickstoffmonoxid-synthase |
| AR032318A1 (es) * | 2000-04-13 | 2003-11-05 | Pharmacia Corp | Compuesto derivado halogenado del acido 2-amino-5,6 heptenoico; composicion farmaceutica que lo comprende y su uso en la fabricacion de un medicamento util como inhibidor de la oxido nitrico sintetasa |
-
2001
- 2001-09-24 US US09/961,521 patent/US20030119826A1/en not_active Abandoned
-
2002
- 2002-09-24 CA CA002455989A patent/CA2455989A1/en not_active Abandoned
- 2002-09-24 EP EP02761804A patent/EP1429752A1/en not_active Withdrawn
- 2002-09-24 MX MXPA04002710A patent/MXPA04002710A/es unknown
- 2002-09-24 PL PL02371774A patent/PL371774A1/xx not_active Application Discontinuation
- 2002-09-24 AU AU2002327042A patent/AU2002327042A2/en not_active Abandoned
- 2002-09-24 BR BR0212989-2A patent/BR0212989A/pt not_active IP Right Cessation
- 2002-09-24 KR KR10-2004-7004170A patent/KR20040039394A/ko not_active Withdrawn
- 2002-09-24 WO PCT/US2002/030214 patent/WO2003026638A1/en not_active Ceased
- 2002-09-24 JP JP2003530275A patent/JP2005508910A/ja active Pending
- 2002-09-24 CN CNA028185935A patent/CN1556698A/zh active Pending
- 2002-09-24 IL IL16100502A patent/IL161005A0/xx unknown
-
2004
- 2004-03-23 ZA ZA200402288A patent/ZA200402288B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GEP20074208B (en) | Substituted amides active at the cannabinoid-1 receptor | |
| US20070021352A1 (en) | Prevention and treatment of hearing disorders | |
| JP2005506352A5 (enExample) | ||
| WO2004020431A3 (en) | Novel benzoimidazole derivatives useful as antiproliferative agents | |
| JP2007535496A5 (enExample) | ||
| MX2007004183A (es) | Derivados de benzoimidazol utiles como agentes antiproliferacion. | |
| WO2005065069A3 (en) | Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer's disease | |
| CY1115484T1 (el) | Ενωσεις, συνθεσεις και μεθοδοι για την θεραπεια αμυλοειδικων ασθενειων και συνουκλεϊνοπαθειων, οπως νοσος alzheimer, διαβητης τυπου 2 και νοσος parkinson | |
| GEP201706611B (en) | Amido compounds and their use as pharmaceuticals | |
| JP2007525510A5 (enExample) | ||
| EP1568361A3 (en) | Sustained-release pharmaceutical composition containing tamsulosin | |
| UA85359C2 (ru) | Таблетка, содержащая гранулированный материал с kmd-3213 | |
| RU2003118411A (ru) | Кристаллические производные 1-метилкарбапенема | |
| CA2321547A1 (en) | Indole derivatives and medicinal compositions containing the same | |
| RU2003100507A (ru) | Фармацевтические композиции | |
| RU2006115784A (ru) | Применение l-бутилфталида для изготовления лекарственного средства для профилактики и лечения церебрального инфаркта | |
| TW200502222A (en) | Use of 10-hydroxy-10,11-dihydrocarbamazepine derivatives for the treatment of affective disorders | |
| ATE361749T1 (de) | Benzthiazol-3 oxide zur behandlung von proliferativen störungen | |
| JP2005532269A5 (enExample) | ||
| CA2441309A1 (en) | Biguanide derivatives | |
| CA2438509A1 (en) | Use of cyclohexenone derivatives for the manufacture of a medicament in the treatment of dysuria | |
| JP2009523142A5 (enExample) | ||
| CA2392630A1 (en) | 2-amino-5,6-dihalo-3,4-dihydroquinazolines with blood platelet reducing properties | |
| RU2007132971A (ru) | Способы и материалы с транс-кломифеном для лечения мужского бесплодия | |
| JP2008538211A5 (enExample) |